Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on SYNECTICS PLC. We currently have 23 research reports from 2 professional analysts.
|24Mar17 14:43||RNS||Posting of Annual Report and AGM Notice|
|07Mar17 09:55||RNS||Director/PDMR Shareholding|
|02Mar17 11:32||RNS||Director/PDMR Shareholding|
|21Feb17 07:00||RNS||Final Results|
|30Jan17 07:00||RNS||Notification of Final Results|
|10Jan17 07:00||RNS||Adoption of Financial Reporting Standard 101|
|08Dec16 07:00||RNS||Year End Trading Update|
Frequency of research reports
Research reports on
Share & share alike
29 Mar 17
In a key week in a number of respects, some of the optimism that buoyed up markets has dissipated. In the UK, inflation istrending higher and above wage growth, putting pressure on the consumer although retail sales show contrasting signs. Corporate action continues apace. Yesterday there were more than fifty company results – all appear to be at least as expected. We now face a prolonged period of pre-Brexit bargaining. In Share News & Views we have covered Cropper (James)*, ECSC*, Gamma Communications, Goodwin*, Helios*, Manx Telecom, Personal Group and Quarto Group.-
M&A coming to a company near you?
16 Mar 17
Markets have retained their relative strength over the last fortnight. We have seen a mixed reaction to the Budget last week, the passing of the Brexit Bill earlier in the week and the first interest rate hike by the Federal Reserve in the US yesterday. Against this backdrop, we have seen some notable M&A activity across a range of sectors which may move down the market capitalisation scale. We now face an extended period of heightened speculation but “no running commentary” regarding Brexit in the UK after Article 50 is triggered at the end of the month.
Indices are not as flat as pancakes
27 Feb 17
On Shrove Tuesday, some of the various small cap indices we follow continue to hit or remain close to all-time highs, benefiting from growing optimism about the global economy. The State of the Union Address to Congress later today and the UK Budget next Wednesday are key forthcoming events that markets await. In the Budget, the updated OBR forecasts regarding the prospects for UK growth and the state of the public finances will no doubt, be the focus. Primarily, the accelerating flow of forthcoming company results will continue to be the key for investors as we await the passage of the Brexit Bill.
Profit growth continuing at a slower pace
21 Feb 17
Boosted by an exceptionally strong gaming performance and currencies Synectics delivered an 83.9% increase in adj. PBT to £2.6m (SSL forecast £2.4m) on revenue of £70.9m (£71.0m) for FY2016. Net cash of £2.2m was also slightly better (£2m) although the 2p dividend was below (3p). We have adjusted our forecasts to reflect a more normal outlook for gaming in FY2017E and we still do not anticipate any meaningful recovery in oil & gas until FY2018E. Despite this we maintain our DCF-derived 315p target price and Buy rating.
Share & share alike
14 Feb 17
The rally in the last fortnight, highlighted in the table, reflects a continued flow of positive updates and economic news. The FTSE 250, Small cap and Fledgling indices have reached record highs. We are in the lull ahead of results for those companies with a December year end, a welter of economic data regarding the UK economy, the State of the Union address in the US on 28 February and the UK Budget on Wednesday 8 March. We will learn at that stage the latest forecasts from the Office of Budget Responsibility. As highlighted previously, the reaction to corporate updates will continue to set the tone.
Half-term report- Satisfactory?
02 Feb 17
The end of (half) term report reads reasonably well. We have survived the company pre-reporting season with sanity just about intact. Updates have been as anticipated and relatively upbeat with some notable exceptions. The microcosm of smaller companies has soldiered on in the face of a myriad of external distractions both political and economic. Most indices other than AIM have surrendered some of the gains achieved over the last quarter. With outlooks remaining broadly positive, the relative undervaluation of microcaps remains. The reaction to corporate updates will continue to set the tone.
N+1 Singer - T. Clarke - Strong conclusion to FY16, record order book
28 Mar 17
After significant upgrades at the time of the full year update (PBT forecast +43% FY16; +14% FY17), today’s results are c.4% ahead of our expectations at the PBT level and show strong growth on the prior year (PBT +48%). All regions achieved positive growth in revenue. The outlook statement refers to a still growing order book (£350m at the end of February vs. £330m at the year end) and the strength of recent trading, with London & the South East and Scotland said to be particularly positive. The Group has reiterated its ambitions to improve margins, but we have not incorporated this into our forecasts at this stage. We have nudged up our FY’17 forecasts (PBT +5%) and introduced FY’18 forecasts that imply 2% PBT growth. Despite the well justified bounce in the share price, the shares still trade at a significant discount to the peer group (7.6x FY17 PE, 4% yield).
Panmure Morning Note 29-03-2017
29 Mar 17
We are cutting our recommendation to HOLD as we see little upside from current levels given the lack of positive surprises in today’s trading update. Multiples of 4.4x 2017 sales and 17x 2017 EBITDA imply an expectation of at least slightly exceeding expectations. We had assumed that acquisitions will provide the momentum until organic investments deliver. However, acquisitions are proving elusive and excess cash is diluting returns. Moreover, our forecast relies on at least one order in vehicle simulator market, which has yet to be announced. The management has shown that it can use the financial markets to raise equity but it now needs to show that it can deploy excess equity productively.
N+1 Singer - Severfield - Strong H2 drives upgrades; CEO temporarily steps down due to ill health
28 Mar 17
Severfield’s trading update highlights that trading during H2 was strong and the Group now expects results to be ahead of expectations. Cash flow performance has been similarly strong with net funds at the year end also expected to be ahead of expectations. The strong performance was driven by both a better than expected revenue performance and better than expected growth in the operating margin. We expect to increase our FY16 PBT forecasts by c.9% to around £19.5m. In addition, we are disappointed to see that Ian Lawson (CEO) has taken a temporary leave of absence due to physical ill health. John Dodds (non-executive Chairman) will step up to Executive Chairman on an interim basis and Alan Dunsmore (FD) has agreed to assume the role of CEO on a similar basis. This should ensure the continuity of the business whilst Ian is recovering. The outlook for Sevefield remains positive and the Group has reiterated its medium term target to double PBT from £13.2m in FY16 by FY20. We remain positive on Severfield (one of our best ideas for 2017) and continue to see clear potential for it to outperform its medium term targets.
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)